Trials / Completed
CompletedNCT01166659
Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Transcend Medical, Inc. · Industry
- Sex
- All
- Age
- 21 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of CyPass implantation as a stand-alone therapy for lowering intraocular pressure (IOP) in patients with primary open angle glaucoma (POAG) who have failed at least one class of topical medical therapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CyPass Micro-Stent | The CyPass Micro-Stent is a small tube with a through-lumen designed to redirect aqueous fluid from the front to the back of the eye. The CyPass is implanted in the eye. |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2013-05-01
- Completion
- 2014-05-01
- First posted
- 2010-07-21
- Last updated
- 2017-05-15
- Results posted
- 2016-10-28
Source: ClinicalTrials.gov record NCT01166659. Inclusion in this directory is not an endorsement.